This article was reviewed by Darragh O’Carroll, MD. PSA and Testosterone: Are They Linked? Prostate-specific antigen (PSA) is ...

Androgens can drive prostate cancer growth, thus providing the rationale for using deprivation of androgens as a first line of treatment for prostate cancer. Unfortunately, prostate cancer cells adapt ...

Over a mean follow-up of 33 months, those who used topical 1.62% testosterone gel had a 0.19% incidence of high-grade prostate cancer (Gleason score ≥4 + 3), similar to the 0.12% among placebo-treated ...

Combining testosterone-blocking drugs in patients with prostate cancer relapse prevents the spread of cancer better than treatment with a single drug, a multi-institution, phase 3 clinical trial led ...

CHICAGO—Metastasis-free survival or overall survival may be a more reliable and meaningful clinical endpoint than PSA relapse in studies of prostate cancer (PCa) patients treated with androgen ...

A man looking at his brush with plenty of hair loss. You’ve been bombarded with health advice since you were a kid, and by now you’re probably pretty adept at spotting the good and ditching bogus info ...

With the prevalent use of opioids in the treatment of acute and chronic pain, the effect on the hypothalamus is often overlooked. Fatigue, low libido and decline in mental function are frequently ...

Clinical markers of successful liquid biopsy-based genomic profiling in veterans with prostate cancer. This is an ASCO Meeting Abstract from the 2022 ASCO Annual Meeting I. This abstract does not ...

SAN ANTONIO -- More than 2 years after treatment, no patient with high-risk prostate cancer had a confirmed biochemical recurrence after receiving postoperative apalutamide (Erleada) and androgen ...

You've been bombarded with health advice since you were a kid, and by now you're probably pretty adept at spotting the good and ditching bogus info. You no longer believe you'll go blind from ...